(Q34018166)

30 July 2017

title

Subretinal fibrosis in patients with Vogt-Koyanagi-Harada disease (English)

1 reference

30 July 2017

Kuo IC

1

1 reference

30 July 2017

Rechdouni A

2

1 reference

30 July 2017

Rao NA

3

1 reference

30 July 2017

Johnston RH

4

1 reference

30 July 2017

Margolis TP

5

1 reference

30 July 2017

Cunningham ET Jr

6

1 reference

30 July 2017

publication date

1 September 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

107

1 reference

30 July 2017

issue

9

1 reference

30 July 2017

page(s)

1721-1728

1 reference

Vogt-Koyanagi-Harada syndrome

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Detection of anticytomegalovirus antibody synthesis in the anterior chamber in Vogt-Koyanagi-Harada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Vogt-Koyanagi-Harada syndrome after cutaneous injury

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

HLA associations and ancestry in Vogt-Koyanagi-Harada disease and sympathetic ophthalmia

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

HLA-DR is strongly associated with Vogt-Koyanagi-Harada disease in Mexican Mestizo patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Vogt-Koyanagi-Harada disease and HLA type in Italian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

HLA-DRB1∗0405 is the Predominant Allele in Brazilian Patients With Vogt-Koyanagi-Harada Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Mechanisms of inflammatory response in sympathetic ophthalmia and VKH syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Incidence and management of cataracts in Vogt-Koyanagi-Harada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Incidence and management of glaucoma in Vogt-Koyanagi-Harada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Subretinal neovascularization in the Vogt-Koyanagi-Harada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Vogt-Koyanagi-Harada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Central serous chorioretinopathy in patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Subretinal Fibrosis in Central Serous Chorioretinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Subretinal Fibrosis in Retinal Detachment

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Ultrastructure of traction retinal detachment in rhesus monkey eyes after a posterior penetrating ocular injury.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Progressive subretinal fibrosis and blindness in patients with multifocal granulomatous chorioretinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Multifocal choroiditis with progressive subretinal fibrosis. Report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Ocular manifestations of onchocerciasis in a rain forest area of west Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Progressive subretinal fibrosis and uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Macular edema in chronic Vogt-Koyanagi-Harada syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

The use of corticosteroids for choroidal neovascularisation in young patients

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

Surgical management of subfoveal neovascularization in children

1 reference

https://api.crossref.org/works/10.1016%2FS0161-6420%2800%2900244-X

7 January 2021

10.1016/S0161-6420(00)00244-X

Identifiers

DOI

1 reference

30 July 2017

1 reference